Research Note Directory

CytoGenix, Inc.
Symbol:  CYGX
Exchange:  BB

08/26/2003.  Results of New Anti-Cancer Research Using CytoGenixís ssDNA Technology to be Published
  (PDF Version)

08/12/2003.  Recent Announcements by CytoGenix Indicate Commercial Product Development is on Track
  (PDF Version)

06/19/2003.  CytoGenix Announces Promising In Vitro Studies; Speculative Buy Maintained
  (PDF Version)

12/13/2002.  Cytogenix Announces Patent Application For The Treatment Of Herpes Simplex Virus (HSV) Utilizing Its ssDNA Technology

12/02/2002.  CytoGenix Continues To Advance Commercial Development Of Its Single-Strand DNA Expression Technology

Disclaimer